Grygorii Tsapko, M.D.

Dr. Grygorii Tsapko is a highly experienced physician and clinical researcher with over 20 years of medical practice and strong expertise in early-phase clinical trials. He specializes in Phase I clinical trials, First-in-Human studies, bioavailability and bioequivalence research, and pharmacokinetics.

Dr. Tsapko earned his medical degree from Luhansk Medical National University, followed by specialization in Orthopedic Traumatology and postgraduate education in Healthcare Management. His clinical background provides a strong foundation in patient care, pain management, and post-operative evaluation.

Dr. Tsapko serves as a Principal Investigator, contributing to early-phase clinical trials with a focus on safety, data integrity, and regulatory compliance. He has participated in over 30 clinical studies, including numerous pharmacokinetic and bioequivalence trials across therapeutic areas such as cardiovascular, metabolic, and pain management. His experience includes conducting studies in accordance with ICH-GCP and EMA regulatory standards, ensuring high-quality and reliable clinical outcomes.